Register entryShortage reported
- Registered sites
- 2
- Active NDC listings
- 242
- Labeller names
- 8
- Live patents
- 10
- Exclusivities
- 1
- Shortage listings
- 25
- Countries
- 1
- Base
- United Kingdom
Authorisation
Registered operations
Analytical testing2Finished drug manufacture1Packaging2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| ACCORD-UK LTD | Whiddon Valley, Whiddon Valley Industrial Estate, Barnstaple, Devon EX32 8NS, United Kingdom (GBR) | Analytical testing, Finished drug manufacture, Packaging | 3006750335216045922 |
| ACCORD HEALTHCARE LIMITED | EDGEFIELD AVE, NEWCASTLE UPON TYNE, NE3 3NB, United Kingdom (GBR) | Analytical testing, Packaging | 3026277693229441106 |
Alert
Drug shortage listings
25| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Current | Available | 1 Jan 202015 Sept 2026 |
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Current | Unavailable | 1 Jan 202015 Sept 2026 |
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Current | Unavailable | 1 Jan 202015 Sept 2026 |
| Azacitidine InjectionOncology | Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Current | Available | 21 Dec 202015 Sept 2026 |
| Carboplatin InjectionOncology | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) | Current | Unavailable | 28 Apr 202315 Sept 2026 |
| Carboplatin InjectionOncology | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) | Current | Unavailable | 28 Apr 202315 Sept 2026 |
| Carboplatin InjectionOncology | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) | Current | Unavailable | 28 Apr 202315 Sept 2026 |
| Carboplatin InjectionOncology | Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) | Current | Unavailable | 28 Apr 202315 Sept 2026 |
| Clonazepam TabletNeurology, Pediatric, Psychiatry | Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Current | Available | 10 Mar 202315 Sept 2026 |
| Clonazepam TabletNeurology, Pediatric, Psychiatry | Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Current | Available | 10 Mar 202315 Sept 2026 |
| Clonazepam TabletNeurology, Pediatric, Psychiatry | Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Current | Available | 10 Mar 202315 Sept 2026 |
| Clonazepam TabletNeurology, Pediatric, Psychiatry | Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Current | Available | 10 Mar 202315 Sept 2026 |
| Clonazepam TabletNeurology, Pediatric, Psychiatry | Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Current | Available | 10 Mar 202315 Sept 2026 |
| Clonazepam TabletNeurology, Pediatric, Psychiatry | Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Current | Available | 10 Mar 202315 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | Current | Unavailable | 10 Apr 202015 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) | Current | Unavailable | 10 Apr 202015 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) | Current | Unavailable | 7 Apr 202015 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) | Current | Unavailable | 7 Apr 202015 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) | Current | Unavailable | 7 Apr 202015 Sept 2026 |
| Methotrexate Sodium InjectionRheumatology, Oncology | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30) | Current | Unavailable | 13 Mar 202315 Sept 2026 |
| Methotrexate Sodium InjectionRheumatology, Oncology | Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35) | Current | Unavailable | 13 Mar 202315 Sept 2026 |
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Current | Unavailable | 1 Jan 20121 Sept 2026 |
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Current | Unavailable | 1 Jan 20121 Sept 2026 |
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Current | Unavailable | 1 Jan 20121 Sept 2026 |
| Dehydrated Alcohol Injection, SolutionCardiovascular | Dehydrated Alcohol, Injection, Solution, 1 mL/1 mL (10 pack) (NDC 16729-710-45) | To Be Discontinued | - | 27 May 202627 May 2026 |
Catalogue
Drug listings by form and route
242242 active NDC listings: 238 human prescription drug, 4 drug for further processing. By marketing category: ANDA 220, BLA 12, NDA 6, DRUG FOR FURTHER PROCESSING 4.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 71 |
| tablet | 66 |
| injection | 24 |
| capsule | 20 |
| injection, powder, lyophilized, for solution | 18 |
| injection, solution | 14 |
| tablet, extended release | 12 |
| capsule, extended release | 4 |
| capsule, delayed release | 2 |
| injection, emulsion | 2 |
| injection, solution, concentrate | 2 |
| ointment | 2 |
| tablet, delayed release | 2 |
| cream | 1 |
| kit | 1 |
| Route | NDCs |
|---|---|
| oral | 172 |
| intravenous | 49 |
| subcutaneous | 13 |
| intramuscular | 11 |
| topical | 3 |
| sublingual | 2 |
| endotracheal | 1 |
| intra-arterial | 1 |
| intramedullary | 1 |
| intrathecal | 1 |
| percutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| accord healthcare inc. | 143 |
| accord healthcare, inc. | 67 |
| accord healthcare, inc., | 10 |
| accord biopharma inc. | 9 |
| accord biopharma, inc. | 5 |
| accord healthcare inc | 3 |
| accord healthcare, inc | 3 |
| accord biopharma inc., | 2 |
Exclusivity
Patents and exclusivities
10| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10646572 | CAMCEVI ETM, CAMCEVI KITleuprolide mesylate | product | Jan 2027 |
| 9744207 | CAMCEVI ETM, CAMCEVI KITleuprolide mesylate | product | Jan 2027 |
| 9572857 | CAMCEVI ETM, CAMCEVI KITleuprolide mesylate | product | Aug 2029 |
| 12133878 | CAMCEVI ETM, CAMCEVI KITleuprolide mesylate | product | Dec 2037 |
| 11717555 | CAMCEVI ETM, CAMCEVI KITleuprolide mesylate | product | Jan 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| CAMCEVI ETMLEUPROLIDE MESYLATE | NS New strength | Aug 2028 |
Catalogue
Marketed products
242Showing 150 of 242.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AMITRIPTYLINE HYDROCHLORIDE | AMITRIPTYLINE HYDROCHLORIDE | tablet, film coated, oral | 16729-171ANDA |
| AMITRIPTYLINE HYDROCHLORIDE | AMITRIPTYLINE HYDROCHLORIDE | tablet, film coated, oral | 16729-175ANDA |
| AMITRIPTYLINE HYDROCHLORIDE | AMITRIPTYLINE HYDROCHLORIDE | tablet, film coated, oral | 16729-176ANDA |
| ARGATROBAN | Argatroban | injection, intravenous | 16729-430NDA |
| ARIPIPRAZOLE | ARIPIPRAZOLE | tablet, oral | 16729-278ANDA |
| ARIPIPRAZOLE | ARIPIPRAZOLE | tablet, oral | 16729-279ANDA |
| ARIPIPRAZOLE | ARIPIPRAZOLE | tablet, oral | 16729-280ANDA |
| ARIPIPRAZOLE | ARIPIPRAZOLE | tablet, oral | 16729-281ANDA |
| ARIPIPRAZOLE | ARIPIPRAZOLE | tablet, oral | 16729-282ANDA |
| ARIPIPRAZOLE | ARIPIPRAZOLE | tablet, oral | 16729-283ANDA |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | tablet, film coated, oral | 16729-044ANDA |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | tablet, film coated, oral | 16729-045ANDA |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | tablet, film coated, oral | 16729-046ANDA |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | tablet, film coated, oral | 16729-047ANDA |
| ATROPINE SULFATE | ATROPINE SULFATE | injection, intravenous | 16729-483ANDA |
| ATROPINE SULFATE | ATROPINE SULFATE | injection, intravenous | 16729-484ANDA |
| Allopurinol | allopurinol | tablet, oral | 16729-134ANDA |
| Allopurinol | ALLOPURINOL | tablet, oral | 16729-135ANDA |
| Anastrozole | Anastrozole | tablet, oral | 16729-035ANDA |
| Atropine Sulfate | Atropine Sulfate | injection, solution, endotracheal, intramedullary, intramuscular, intravenous, subcutaneous | 16729-512ANDA |
| Azacitidine | Azacitidine | injection, powder, lyophilized, for solution, intravenous, subcutaneous | 16729-306ANDA |
| BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | tablet, sublingual | 16729-549ANDA |
| BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | tablet, sublingual | 16729-550ANDA |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | tablet, extended release, oral | 16729-443ANDA |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | tablet, extended release, oral | 16729-444ANDA |
| Bicalutamide | Bicalutamide | tablet, oral | 16729-023ANDA |
| Bivalirudin | bivalirudin | injection, powder, lyophilized, for solution, intravenous | 16729-275ANDA |
| Buspirone Hydrochloride | Buspirone Hydrochloride | tablet, oral | 16729-200ANDA |
| Buspirone Hydrochloride | Buspirone Hydrochloride | tablet, oral | 16729-201ANDA |
| Buspirone Hydrochloride | Buspirone Hydrochloride | tablet, oral | 16729-202ANDA |
| Buspirone Hydrochloride | Buspirone Hydrochloride | tablet, oral | 16729-203ANDA |
| Buspirone Hydrochloride | Buspirone Hydrochloride | tablet, oral | 16729-289ANDA |
| Busulfan | busulfan | injection, intravenous | 16729-351ANDA |
| CAMCEVI | LEUPROLIDE | injection, emulsion, subcutaneous | 69448-014NDA |
| CAMCEVI | leuprolide | injection, emulsion, subcutaneous | 69448-023NDA |
| CAPECITABINE | CAPECITABINE | tablet, film coated, oral | 16729-072ANDA |
| CAPECITABINE | CAPECITABINE | tablet, film coated, oral | 16729-073ANDA |
| CARBIDOPA AND LEVODOPA | Carbidopa and Levodopa | tablet, extended release, oral | 16729-078ANDA |
| CARBIDOPA AND LEVODOPA | Carbidopa and Levodopa | tablet, extended release, oral | 16729-079ANDA |
| CINACALCET | Cinacalcet | tablet, film coated, oral | 16729-440ANDA |
| CINACALCET | Cinacalcet | tablet, film coated, oral | 16729-441ANDA |
| CINACALCET | Cinacalcet | tablet, film coated, oral | 16729-442ANDA |
| Carboplatin | Carboplatin | injection, intravenous | 16729-295ANDA |
| Cisplatin | Cisplatin | injection, intravenous | 16729-288ANDA |
| Clomiphene Citrate | Clomiphene Citrate | tablet, oral | 16729-723ANDA |
| Clonazepam | clonazepam | tablet, oral | 16729-136ANDA |
| Clonazepam | clonazepam | tablet, oral | 16729-137ANDA |
| Clonazepam | clonazepam | tablet, oral | 16729-138ANDA |
| Clozapine | clozapine | tablet, oral | 16729-141ANDA |
| Clozapine | clozapine | tablet, oral | 16729-142ANDA |
| DAPTOMYCIN | Daptomycin | injection, powder, lyophilized, for solution, intravenous | 16729-435ANDA |
| DEHYDRATED ALCOHOL | ALCOHOL | injection, solution, percutaneous | 16729-710ANDA |
| DIMETHYL FUMARATE | Dimethyl fumarate | capsule, delayed release, oral | 16729-416ANDA |
| DIMETHYL FUMARATE | Dimethyl fumarate | capsule, delayed release, oral | 16729-417ANDA |
| DOCETAXEL | docetaxel | injection, solution, concentrate, intravenous | 16729-267NDA |
| Dalfampridine | Dalfampridine | tablet, film coated, extended release, oral | 16729-292ANDA |
| Daptomycin | Daptomycin | injection, powder, lyophilized, for solution, intravenous | 16729-434ANDA |
| Decitabine | decitabine | injection, powder, lyophilized, for solution, intravenous | 16729-224ANDA |
| Dexmedetomidine | Dexmedetomidine | injection, solution, intravenous | 16729-239ANDA |
| Diltiazem Hydrochloride | Diltiazem Hydrochloride | capsule, extended release, oral | 16729-303ANDA |
| Diltiazem Hydrochloride | Diltiazem Hydrochloride | capsule, extended release, oral | 16729-304ANDA |
| Diltiazem Hydrochloride | Diltiazem Hydrochloride | capsule, extended release, oral | 16729-305ANDA |
| Dofetilide | Dofetilide | capsule, oral | 16729-490ANDA |
| Dofetilide | Dofetilide | capsule, oral | 16729-491ANDA |
| Dofetilide | Dofetilide | capsule, oral | 16729-492ANDA |
| Doxazosin | Doxazosin | tablet, oral | 16729-211ANDA |
| Doxazosin | Doxazosin | tablet, oral | 16729-213ANDA |
| Doxazosin | Doxazosin | tablet, oral | 16729-414ANDA |
| Doxazosin | Doxazosin | tablet, oral | 16729-415ANDA |
| EZETIMIBE | EZETIMIBE | tablet, oral | 16729-433ANDA |
| Eplerenone | Eplerenone | tablet, film coated, oral | 16729-293ANDA |
| Eplerenone | Eplerenone | tablet, film coated, oral | 16729-294ANDA |
| Escitalopram | Escitalopram | tablet, film coated, oral | 16729-168ANDA |
| Escitalopram | Escitalopram | tablet, film coated, oral | 16729-169ANDA |
| Escitalopram | Escitalopram | tablet, film coated, oral | 16729-170ANDA |
| Etoposide | Etoposide | injection, intravenous | 16729-114ANDA |
| FILKRI | filgrastim-laha | injection, solution, intravenous, subcutaneous | 69448-008BLA |
| FILKRI | filgrastim-laha | injection, solution, intravenous, subcutaneous | 69448-009BLA |
| FINGOLIMOD HYDROCHLORIDE | FINGOLIMOD HYDROCHLORIDE | capsule, oral | 16729-342ANDA |
| FULVESTRANT | Fulvestrant | injection, intramuscular | 16729-436ANDA |
| Finasteride | Finasteride | tablet, film coated, oral | 16729-089ANDA |
| Finasteride | finasteride | tablet, film coated, oral | 16729-090ANDA |
| Fluorouracil | Fluorouracil | injection, solution, intravenous | 16729-276ANDA |
| Fluorouracil | Fluorouracil | cream, topical | 16729-542ANDA |
| Furosemide | Furosemide | injection, intramuscular, intravenous | 16729-500ANDA |
| Furosemide | Furosemide | injection, intramuscular, intravenous | 16729-501ANDA |
| Furosemide | Furosemide | injection, intramuscular, intravenous | 16729-502ANDA |
| Glimepiride | Glimepiride | tablet, oral | 16729-001ANDA |
| Glimepiride | Glimepiride | tablet, oral | 16729-002ANDA |
| Glimepiride | Glimepiride | tablet, oral | 16729-003ANDA |
| Glycopyrrolate | glycopyrrolate | injection, intramuscular, intravenous | 16729-471ANDA |
| Glycopyrrolate | glycopyrrolate | injection, intramuscular, intravenous | 16729-472ANDA |
| Glycopyrrolate | glycopyrrolate | injection, intramuscular, intravenous | 16729-473ANDA |
| Glycopyrrolate | glycopyrrolate | injection, intramuscular, intravenous | 16729-474ANDA |
| HERCESSI | Trastuzumab-strf | injection, powder, lyophilized, for solution, intravenous | 69448-015BLA |
| HERCESSI | Trastuzumab-strf | injection, powder, lyophilized, for solution, intravenous | 69448-016BLA |
| Hydrochlorothiazide | Hydrochlorothiazide | tablet, oral | 16729-182ANDA |
| Hydrochlorothiazide | Hydrochlorothiazide | tablet, oral | 16729-183ANDA |
| Hydrochlorothiazide | Hydrochlorothiazide | tablet, oral | 16729-184ANDA |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | tablet, oral | 16729-485ANDA |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | tablet, oral | 16729-561ANDA |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | tablet, oral | 16729-562ANDA |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | tablet, oral | 16729-563ANDA |
| IMULDOSA | ustekinumab-srlf | injection, subcutaneous | 69448-017BLA |
| IMULDOSA | ustekinumab-srlf | injection, subcutaneous | 69448-018BLA |
| IMULDOSA | ustekinumab-srlf | injection, intravenous | 69448-019BLA |
| JUBEREQ | denosumab-desu | injection, subcutaneous | 69448-022BLA |
| Lenalidomide | Lenalidomide | capsule, oral | 16729-692ANDA |
| Lenalidomide | Lenalidomide | capsule, oral | 16729-693ANDA |
| Lenalidomide | Lenalidomide | capsule, oral | 16729-694ANDA |
| Lenalidomide | Lenalidomide | capsule, oral | 16729-695ANDA |
| Lenalidomide | Lenalidomide | capsule, oral | 16729-696ANDA |
| Lenalidomide | Lenalidomide | capsule, oral | 16729-697ANDA |
| Letrozole | letrozole | tablet, film coated, oral | 16729-034ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-447ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-448ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-449ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-450ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-451ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-452ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-453ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-454ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-455ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-456ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-457ANDA |
| Levothyroxine sodium | Levothyroxine Sodium | tablet, oral | 16729-458ANDA |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | tablet, oral | 16729-478ANDA |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | tablet, oral | 16729-479ANDA |
| METHYLPHENIDATE HYDROCHLORIDE | METHYLPHENIDATE HYDROCHLORIDE | tablet, oral | 16729-480ANDA |
| MUTAMYCIN | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 69448-001ANDA |
| MUTAMYCIN | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 69448-003ANDA |
| Methotrexate | Methotrexate | injection, intra-arterial, intramuscular, intrathecal, intravenous | 16729-277ANDA |
| Methotrexate | Methotrexate | tablet, oral | 16729-486ANDA |
| Mitomycin | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 16729-108ANDA |
| Mitomycin | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 16729-115ANDA |
| Mitomycin | Mitomycin | injection, powder, lyophilized, for solution, intravenous | 16729-116ANDA |
| Montelukast Sodium | Montelukast Sodium | tablet, film coated, oral | 16729-119ANDA |
| Mycophenolic Acid | Mycophenolic Acid | tablet, delayed release, oral | 16729-189ANDA |
| Mycophenolic Acid | Mycophenolic Acid | tablet, delayed release, oral | 16729-261ANDA |
| Naltrexone Hydrochloride | Naltrexone Hydrochloride | tablet, film coated, oral | 16729-081ANDA |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | tablet, film coated, oral | 16729-366ANDA |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | tablet, film coated, oral | 16729-367ANDA |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | tablet, film coated, oral | 16729-368ANDA |
| OSVYRTI | denosumab-desu | injection, subcutaneous | 69448-021BLA |
| PEMETREXED | Pemetrexed | injection, powder, lyophilized, for solution, intravenous | 16729-229ANDA |
| PEMETREXED | Pemetrexed | injection, powder, lyophilized, for solution, intravenous | 16729-230ANDA |
| PEMETREXED | Pemetrexed | injection, powder, lyophilized, for solution, intravenous | 16729-244ANDA |
| PIRFENIDONE | PIRFENIDONE | tablet, film coated, oral | 16729-467ANDA |
| PIRFENIDONE | PIRFENIDONE | tablet, film coated, oral | 16729-468ANDA |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | tablet, oral | 16729-008ANDA |
Compare
Comparable companies in United Kingdom
- Mondelez Global LLC2 sites · 27 NDC
- Terumo BCT, Inc2 sites · 8 NDC
- Replimune Group, Inc.2 sites · 2 NDC
- Aptuit Global LLC2 sites · 0 NDC
- DRUG DEVELOPMENT SOLUTIONS LIMITED TRADING AS RESOLIAN2 sites · 0 NDC
- Norbrook Laboratories Limited2 sites · 0 NDC
- Croda Europe Ltd.3 sites · 51 NDC
- DSM Nutritional Products France SAS3 sites · 30 NDC
- PENN PHARMACEUTICALS LIMITED1 site · 24 NDC
- BTG International Inc1 site · 10 NDC
Enquiry
Common questions
- Is ACCORD HEALTHCARE LIMITED FDA approved?
- ACCORD HEALTHCARE LIMITED holds 2 FDA-registered establishments in the United Kingdom. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are ACCORD HEALTHCARE LIMITED's drugs manufactured?
- The FDA register lists Barnstaple; NEWCASTLE UPON TYNE. Registered operations: analytical testing, finished drug manufacture, packaging.
- What drugs does ACCORD HEALTHCARE LIMITED make?
- 242 products are listed under ACCORD HEALTHCARE LIMITED in the openFDA NDC Directory, most often as tablet, film coated; tablet; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any ACCORD HEALTHCARE LIMITED products in shortage?
- 24 presentations are currently listed in the FDA drug shortage database under ACCORD HEALTHCARE LIMITED, covering Atropine Sulfate Injection, Azacitidine Injection, Carboplatin Injection and 4 other drugs.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.